Amarin Corporation plc (AMRN)
USD 0.4
(-6.25%)
USD 0.4
(-6.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 279.58 Million USD | -3.87% |
| 2022 | 290.84 Million USD | -27.46% |
| 2021 | 400.96 Million USD | 18.45% |
| 2020 | 338.51 Million USD | 23.57% |
| 2019 | 273.94 Million USD | 17.38% |
| 2018 | 233.38 Million USD | 2.95% |
| 2017 | 226.69 Million USD | 28.76% |
| 2016 | 176.05 Million USD | -41.83% |
| 2015 | 302.65 Million USD | 16.6% |
| 2014 | 259.55 Million USD | -9.35% |
| 2013 | 286.33 Million USD | -9.06% |
| 2012 | 314.85 Million USD | 137.91% |
| 2011 | 132.34 Million USD | -44.33% |
| 2010 | 237.73 Million USD | 3030.14% |
| 2009 | 7.59 Million USD | -2.11% |
| 2008 | 7.75 Million USD | -57.14% |
| 2007 | 18.1 Million USD | 64.73% |
| 2006 | 10.99 Million USD | 34.36% |
| 2005 | 8.18 Million USD | 16.39% |
| 2004 | 7.02 Million USD | -86.92% |
| 2003 | 53.72 Million USD | -48.22% |
| 2002 | 103.74 Million USD | 69.17% |
| 2001 | 61.32 Million USD | 251.88% |
| 2000 | 17.42 Million USD | -19.21% |
| 1999 | 21.57 Million USD | -28.1% |
| 1998 | 30 Million USD | 17.65% |
| 1997 | 25.5 Million USD | 18.06% |
| 1996 | 21.6 Million USD | 222.39% |
| 1995 | 6.7 Million USD | 0.0% |
| 1993 | 5.9 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 244.07 Million USD | -12.7% |
| 2024 Q3 | 219.24 Million USD | -11.59% |
| 2024 Q2 | 247.97 Million USD | 1.6% |
| 2023 Q3 | 285.88 Million USD | -1.72% |
| 2023 Q1 | 275.39 Million USD | -5.31% |
| 2023 Q2 | 290.89 Million USD | 5.63% |
| 2023 FY | 279.58 Million USD | -3.87% |
| 2023 Q4 | 279.58 Million USD | -2.2% |
| 2022 FY | 290.84 Million USD | -27.46% |
| 2022 Q1 | 332.6 Million USD | -17.05% |
| 2022 Q2 | 393.19 Million USD | 18.22% |
| 2022 Q4 | 290.84 Million USD | -9.25% |
| 2022 Q3 | 320.47 Million USD | -18.49% |
| 2021 Q3 | 393.31 Million USD | -1.59% |
| 2021 Q2 | 399.66 Million USD | 12.38% |
| 2021 FY | 400.96 Million USD | 18.45% |
| 2021 Q4 | 400.96 Million USD | 1.95% |
| 2021 Q1 | 355.64 Million USD | 5.06% |
| 2020 Q2 | 312.1 Million USD | -8.17% |
| 2020 Q1 | 339.89 Million USD | 24.07% |
| 2020 Q3 | 352.94 Million USD | 13.09% |
| 2020 Q4 | 338.51 Million USD | -4.09% |
| 2020 FY | 338.51 Million USD | 23.57% |
| 2019 Q2 | 240.83 Million USD | 4.09% |
| 2019 Q1 | 231.36 Million USD | -0.86% |
| 2019 FY | 273.94 Million USD | 17.38% |
| 2019 Q4 | 273.94 Million USD | 1.07% |
| 2019 Q3 | 271.04 Million USD | 12.54% |
| 2018 Q4 | 233.38 Million USD | -11.3% |
| 2018 FY | 233.38 Million USD | 2.95% |
| 2018 Q1 | 232.36 Million USD | 2.5% |
| 2018 Q2 | 250.81 Million USD | 7.94% |
| 2018 Q3 | 263.11 Million USD | 4.9% |
| 2017 Q3 | 212.72 Million USD | 1.81% |
| 2017 FY | 226.69 Million USD | 28.76% |
| 2017 Q1 | 203.97 Million USD | 15.86% |
| 2017 Q2 | 208.94 Million USD | 2.44% |
| 2017 Q4 | 226.69 Million USD | 6.57% |
| 2016 FY | 176.05 Million USD | -41.83% |
| 2016 Q3 | 178.72 Million USD | -42.73% |
| 2016 Q4 | 176.05 Million USD | -1.49% |
| 2016 Q2 | 312.05 Million USD | 1.04% |
| 2016 Q1 | 308.84 Million USD | 2.05% |
| 2015 FY | 302.65 Million USD | 16.6% |
| 2015 Q3 | 293.51 Million USD | 2.44% |
| 2015 Q1 | 277.16 Million USD | 6.78% |
| 2015 Q2 | 286.51 Million USD | 3.37% |
| 2015 Q4 | 302.65 Million USD | 3.11% |
| 2014 Q3 | 254.61 Million USD | -0.47% |
| 2014 Q1 | 277.8 Million USD | -2.98% |
| 2014 Q2 | 255.81 Million USD | -7.91% |
| 2014 Q4 | 259.55 Million USD | 1.94% |
| 2014 FY | 259.55 Million USD | -9.35% |
| 2013 FY | 286.33 Million USD | -9.06% |
| 2013 Q1 | 331.41 Million USD | 5.26% |
| 2013 Q2 | 309 Million USD | -6.76% |
| 2013 Q4 | 286.33 Million USD | -8.09% |
| 2013 Q3 | 311.54 Million USD | 0.82% |
| 2012 Q4 | 314.85 Million USD | 23.49% |
| 2012 Q3 | 254.96 Million USD | -4.1% |
| 2012 FY | 314.85 Million USD | 137.91% |
| 2012 Q2 | 265.85 Million USD | -18.26% |
| 2012 Q1 | 325.25 Million USD | 145.77% |
| 2011 Q3 | 162 Million USD | -44.18% |
| 2011 Q1 | 179.25 Million USD | -24.6% |
| 2011 FY | 132.34 Million USD | -44.33% |
| 2011 Q2 | 290.23 Million USD | 61.91% |
| 2011 Q4 | 132.34 Million USD | -18.31% |
| 2010 Q4 | 237.73 Million USD | 0.0% |
| 2010 FY | 237.73 Million USD | 3030.14% |
| 2010 Q2 | 6.14 Million USD | 0.0% |
| 2009 FY | 7.59 Million USD | -2.11% |
| 2009 Q2 | 11.85 Million USD | 0.0% |
| 2009 Q4 | 7.59 Million USD | 0.0% |
| 2008 FY | 7.75 Million USD | -57.14% |
| 2008 Q2 | 10.45 Million USD | -31.66% |
| 2008 Q1 | 15.29 Million USD | -15.54% |
| 2007 Q4 | 18.1 Million USD | 111.66% |
| 2007 Q2 | 10.33 Million USD | -0.45% |
| 2007 Q1 | 10.38 Million USD | -5.54% |
| 2007 FY | 18.1 Million USD | 64.73% |
| 2007 Q3 | 8.55 Million USD | -17.23% |
| 2006 Q2 | 7.07 Million USD | 5.6% |
| 2006 FY | 10.99 Million USD | 34.36% |
| 2006 Q4 | 10.99 Million USD | 43.73% |
| 2006 Q3 | 7.64 Million USD | 8.1% |
| 2006 Q1 | 6.69 Million USD | -18.11% |
| 2005 Q4 | 8.18 Million USD | 0.0% |
| 2005 Q2 | 4.3 Million USD | 0.0% |
| 2005 FY | 8.18 Million USD | 16.39% |
| 2004 Q4 | 7.02 Million USD | 40.56% |
| 2004 Q3 | 5 Million USD | -36.7% |
| 2004 Q2 | 7.89 Million USD | 0.0% |
| 2004 FY | 7.02 Million USD | -86.92% |
| 2003 Q2 | 65.32 Million USD | 0.0% |
| 2003 FY | 53.72 Million USD | -48.22% |
| 2003 Q4 | 53.72 Million USD | -55.72% |
| 2003 Q3 | 121.32 Million USD | 85.72% |
| 2002 Q4 | 103.74 Million USD | 0.0% |
| 2002 FY | 103.74 Million USD | 69.17% |
| 2001 Q4 | 61.32 Million USD | 0.0% |
| 2001 FY | 61.32 Million USD | 251.88% |
| 2000 Q4 | 17.42 Million USD | 0.0% |
| 2000 FY | 17.42 Million USD | -19.21% |
| 1999 FY | 21.57 Million USD | -28.1% |
| 1998 FY | 30 Million USD | 17.65% |
| 1998 Q3 | 30 Million USD | 0.0% |
| 1997 Q3 | 25.5 Million USD | 0.0% |
| 1997 FY | 25.5 Million USD | 18.06% |
| 1996 Q3 | 21.6 Million USD | 0.0% |
| 1996 FY | 21.6 Million USD | 222.39% |
| 1995 FY | 6.7 Million USD | 0.0% |
| 1995 Q3 | 6.7 Million USD | 0.0% |
| 1993 FY | 5.9 Million USD | 0.0% |
| 1993 Q3 | 5.9 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 16.734% |
| Alkermes plc | 933.53 Million USD | 70.051% |
| Agenus Inc. | 462.29 Million USD | 39.522% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.098% |
| Aptorum Group Limited | 5.25 Million USD | -5218.641% |
| Ardelyx, Inc. | 130.76 Million USD | -113.812% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 41.557% |
| Bicycle Therapeutics plc | 224.41 Million USD | -24.586% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -114.72% |
| ChromaDex Corporation | 26.5 Million USD | -954.727% |
| Chimerix, Inc. | 19.74 Million USD | -1315.989% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -694.798% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -285.281% |
| CRISPR Therapeutics AG | 346.76 Million USD | 19.373% |
| Precision BioSciences, Inc. | 140.92 Million USD | -98.401% |
| Dyadic International, Inc. | 2.34 Million USD | -11844.839% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1619.16% |
| Fortress Biotech, Inc. | 165.93 Million USD | -68.488% |
| Lantern Pharma Inc. | 2.73 Million USD | -10105.089% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -291.14% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7823.173% |
| Incyte Corporation | 1.59 Billion USD | 82.441% |
| IO Biotech, Inc. | 17.55 Million USD | -1492.544% |
| Jaguar Health, Inc. | 45.86 Million USD | -509.574% |
| Novavax, Inc. | 2.57 Billion USD | 89.131% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -675.381% |
| Opthea Limited | 264.6 Million USD | -5.664% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -113.904% |
| ContextLogic Inc. | 206 Million USD | -35.722% |
| MiMedx Group, Inc. | 96.33 Million USD | -190.239% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -482.206% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7822.81% |
| NextCure, Inc. | 14.99 Million USD | -1764.286% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6817.046% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -4087.315% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -498.188% |
| Vaxcyte, Inc. | 167.44 Million USD | -66.968% |
| PDS Biotechnology Corporation | 33.25 Million USD | -740.632% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -18.865% |
| Pharming Group N.V. | 244.07 Million USD | -14.551% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2245.135% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -118.785% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4131.5% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4131.5% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -239.169% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -4108.746% |
| Acelyrin, Inc. | 86.35 Million USD | -223.772% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -21419.256% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1844.412% |
| Summit Therapeutics Inc. | 125.25 Million USD | -123.211% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2849.541% |
| Senti Biosciences, Inc. | 52.57 Million USD | -431.827% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -306.512% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -84.531% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -14193.814% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -20834.002% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -23.257% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2884.808% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -22.925% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 43.462% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2461.728% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -916.273% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2209.739% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 42.543% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7412.179% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -639.413% |
| MEI Pharma, Inc. | 8.35 Million USD | -3246.344% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -863.595% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 19.562% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -91.67% |
| Fortress Biotech, Inc. | 165.93 Million USD | -68.488% |
| Precigen, Inc. | 41.64 Million USD | -571.374% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -459.958% |
| AlloVir, Inc. | 45.01 Million USD | -521.097% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -114.511% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -102.893% |
| ImmuCell Corporation | 18.81 Million USD | -1385.977% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -890.53% |
| Onconetix, Inc. | 23.18 Million USD | -1106.11% |
| PureTech Health plc | 125.58 Million USD | -122.631% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -3023.877% |
| Elevation Oncology, Inc. | 34.28 Million USD | -715.55% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -11335.051% |
| Seer, Inc. | 39.36 Million USD | -610.243% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -352.157% |
| Innoviva, Inc. | 568.55 Million USD | 50.825% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -926.836% |
| ESSA Pharma Inc. | 3.49 Million USD | -7899.466% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3950.768% |
| GT Biopharma, Inc. | 6.63 Million USD | -4115.091% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -5.748% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -2.681% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -232.739% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2760.518% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -929.066% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8567.287% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -279.014% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1668.564% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2432.563% |
| Soligenix, Inc. | 7.27 Million USD | -3743.171% |
| Century Therapeutics, Inc. | 175.94 Million USD | -58.91% |
| Kura Oncology, Inc. | 51.66 Million USD | -441.185% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -130.526% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6664.747% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4127.293% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -10.685% |
| Autolus Therapeutics plc | 263.9 Million USD | -5.941% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2567.306% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -214.634% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -496.147% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 20.765% |
| GRI Bio, Inc. | 2.69 Million USD | -10266.593% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -34434.607% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -799.254% |
| IGM Biosciences, Inc. | 220.17 Million USD | -26.983% |
| INmune Bio, Inc. | 18.86 Million USD | -1382.277% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -9.01% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -949.429% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10184.961% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -8423.303% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -378.294% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -190.755% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -5.61% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 66.03% |
| Verastem, Inc. | 71.18 Million USD | -292.761% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -468.544% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -624.732% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -471.379% |
| Histogen Inc. | 5.69 Million USD | -4807.618% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -6275.107% |
| Surrozen, Inc. | 8.14 Million USD | -3332.621% |
| Organovo Holdings, Inc. | 2.74 Million USD | -10074.199% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -88980.731% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -397.221% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1593.235% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -447.105% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -33712.487% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -120.625% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2485.515% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -85.293% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10623.054% |
| Apollomics, Inc. | 14.15 Million USD | -1875.461% |
| Mesoblast Limited | 188.79 Million USD | -48.088% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1876.159% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -54.649% |
| Synaptogenix, Inc. | 5.52 Million USD | -4956.308% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -4105.581% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -64.359% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3167.275% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -15809.19% |
| Exelixis, Inc. | 678.44 Million USD | 58.79% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1072.666% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -70.432% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 52.948% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2517.806% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -17120.02% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -618.234% |
| Gritstone bio, Inc. | 125.91 Million USD | -122.037% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1805.063% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5394.35% |
| Avid Bioservices, Inc. | 275.66 Million USD | -1.422% |
| Insmed Incorporated | 1.66 Billion USD | 83.175% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3533.82% |
| MediWound Ltd. | 27.18 Million USD | -928.385% |
| OmniAb, Inc. | 87.4 Million USD | -219.894% |
| Alector, Inc. | 487.66 Million USD | 42.669% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 30.702% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1417.433% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -628.603% |
| Zai Lab Limited | 240.17 Million USD | -16.409% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 55.625% |
| Aura Biosciences, Inc. | 29.22 Million USD | -856.605% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -194.064% |
| Immunic, Inc. | 25.36 Million USD | -1002.125% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -303.817% |
| Veracyte, Inc. | 93.71 Million USD | -198.325% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10584.828% |
| FibroGen, Inc. | 585.72 Million USD | 52.267% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1508.393% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -42710.791% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4843.667% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.348% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3310.429% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -232.755% |
| TG Therapeutics, Inc. | 169.08 Million USD | -65.353% |
| Galecto, Inc. | 5.89 Million USD | -4641.978% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3275.024% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.322% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -870.047% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2115.252% |
| XBiotech Inc. | 8.39 Million USD | -3229.606% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1805.063% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -425.737% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 23.001% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -939.975% |
| Theravance Biopharma, Inc. | 169 Million USD | -65.432% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 77.0% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 44.13% |
| Vaxxinity, Inc. | 30.94 Million USD | -803.526% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 71.25% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4535.749% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 62.483% |
| NexImmune, Inc. | 5.08 Million USD | -5399.1% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -75180.43% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8992.71% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.066% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5324.629% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3650.613% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -963.311% |
| Ainos, Inc. | 7.39 Million USD | -3681.155% |
| Pluri Inc. | 34.11 Million USD | -719.615% |
| Prothena Corporation plc | 135.01 Million USD | -107.075% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -15.008% |
| Celularity Inc. | 102.92 Million USD | -171.631% |
| Rallybio Corporation | 9.43 Million USD | -2862.982% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1043.739% |
| MeiraGTx Holdings plc | 319.99 Million USD | 12.627% |
| Omeros Corporation | 403.25 Million USD | 30.667% |
| Humacyte, Inc. | 114.67 Million USD | -143.804% |
| Immunocore Holdings plc | 228.15 Million USD | -22.541% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5635.118% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -264.33% |
| Blueprint Medicines Corporation | 918.64 Million USD | 69.565% |
| CalciMedica, Inc. | 4.02 Million USD | -6841.087% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1502.034% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -81.382% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -225.794% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -0.646% |
| Pulmatrix, Inc. | 15.96 Million USD | -1651.469% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1672.567% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1036.255% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -11.475% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -450.52% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 76.906% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -779.675% |
| Nutriband Inc. | 1.07 Million USD | -25813.623% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2529.427% |
| Vor Biopharma Inc. | 59.1 Million USD | -373.042% |
| Roivant Sciences Ltd. | 773.95 Million USD | 63.875% |
| Evogene Ltd. | 17.99 Million USD | -1454.125% |
| ProKidney Corp. | 29.21 Million USD | -856.965% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -288.429% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -39558.687% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 85.199% |
| CorMedix Inc. | 11.91 Million USD | -2246.015% |
| BioLineRx Ltd. | 50.7 Million USD | -451.432% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -87.066% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -216.128% |
| Atai Life Sciences N.V. | 49.16 Million USD | -468.706% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -797.484% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1456.547% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -124.323% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4844.942% |
| MediciNova, Inc. | 3.89 Million USD | -7084.458% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1429.553% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18486.583% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7843.081% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 29.621% |
| Biomea Fusion, Inc. | 30.69 Million USD | -811.004% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 89.728% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1651.579% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -796.083% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -376.428% |
| Absci Corporation | 58.3 Million USD | -379.533% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1367.802% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -772.02% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -278.896% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -219.59% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -727.915% |
| Allakos Inc. | 74.79 Million USD | -273.814% |
| Imunon, Inc. | 8.53 Million USD | -3177.526% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1142.554% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -143.517% |
| BioAtla, Inc. | 48.98 Million USD | -470.749% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2517.806% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -9960.705% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -114.072% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1866.845% |
| XOMA Corporation | 145.58 Million USD | -92.05% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -730.498% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -306.619% |
| aTyr Pharma, Inc. | 31.59 Million USD | -784.853% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -352.238% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -521.788% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -477.635% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9641.707% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3327.144% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5999.193% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1476.636% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 83.05% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -69120.466% |
| UroGen Pharma Ltd. | 243.52 Million USD | -14.809% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 12.925% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -10024.249% |
| Orgenesis Inc. | 35.53 Million USD | -686.793% |
| Entera Bio Ltd. | 1.37 Million USD | -20174.619% |
| GH Research PLC | 6.7 Million USD | -4072.318% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -4011.574% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1385.111% |
| Xencor, Inc. | 283.55 Million USD | 1.401% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -9264.281% |
| Replimune Group, Inc. | 113.21 Million USD | -146.954% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -7341.514% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -170.054% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -69120.466% |
| Portage Biotech Inc. | 4.45 Million USD | -6182.854% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18486.583% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1112.959% |
| OncoCyte Corporation | 49.29 Million USD | -467.137% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6658.525% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -34958.634% |
| Purple Biotech Ltd. | 10 Million USD | -2694.473% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4732.129% |
| scPharmaceuticals Inc. | 57.26 Million USD | -388.268% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2156.914% |
| HilleVax, Inc. | 78.9 Million USD | -254.316% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5436.376% |
| Tharimmune, Inc. | 1.81 Million USD | -15303.852% |
| Genprex, Inc. | 3.25 Million USD | -8491.553% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -930.964% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -5239.706% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -135621.845% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -77877.565% |
| OKYO Pharma Limited | 7.42 Million USD | -3667.589% |
| Savara Inc. | 37.19 Million USD | -651.74% |
| Curis, Inc. | 57.61 Million USD | -385.293% |
| Daré Bioscience, Inc. | 26.32 Million USD | -961.863% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -613.236% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -19261.981% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1242.942% |
| BeiGene, Ltd. | 2.23 Billion USD | 87.483% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1213.244% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -6.551% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1214.219% |
| Erasca, Inc. | 78.61 Million USD | -255.659% |
| bluebird bio, Inc. | 424.62 Million USD | 34.157% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -42568.622% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 85.207% |
| DBV Technologies S.A. | 42.8 Million USD | -553.241% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -42568.622% |
| Moderna, Inc. | 4.57 Billion USD | 93.885% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3896.955% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -16783.273% |
| Molecular Templates, Inc. | 31.17 Million USD | -796.946% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1537.885% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 52.46% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -124.559% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -919.014% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -666.916% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -402.538% |
| MacroGenics, Inc. | 154.2 Million USD | -81.306% |
| RenovoRx, Inc. | 4.46 Million USD | -6160.345% |
| Adicet Bio, Inc. | 37.12 Million USD | -653.198% |
| Prime Medicine, Inc. | 60.78 Million USD | -359.998% |
| Aditxt, Inc. | 28.53 Million USD | -879.922% |
| Adagene Inc. | 45.16 Million USD | -518.975% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -154623.549% |
| Quantum-Si incorporated | 26.63 Million USD | -949.855% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 59.92% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -9089.571% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -143.202% |
| SciSparc Ltd. | 1.59 Million USD | -17428.966% |
| Vericel Corporation | 127.7 Million USD | -118.932% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4924.121% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -227.546% |
| Generation Bio Co. | 171.63 Million USD | -62.901% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2320.667% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -568.373% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -10.641% |
| Invivyd, Inc. | 51.71 Million USD | -440.651% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -203.975% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -4197.866% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -270.334% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -27283.643% |
| 2seventy bio, Inc. | 310.12 Million USD | 9.847% |
| ADMA Biologics, Inc. | 193.97 Million USD | -44.135% |
| Clene Inc. | 38.95 Million USD | -617.792% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -673.775% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -8.799% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7843.081% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -46.948% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2195.523% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -40.976% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2192.674% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -481.129% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -429.11% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 24.406% |
| Evaxion Biotech A/S | 17.61 Million USD | -1486.986% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -73.733% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -82.515% |
| Trevena, Inc. | 48.26 Million USD | -479.311% |
| Surrozen, Inc. | 8.14 Million USD | -3332.621% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1194.684% |
| Cingulate Inc. | 10.36 Million USD | -2598.491% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -10066.8% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -649.724% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7695.495% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2026.137% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 11.858% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1025.144% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7644.775% |
| Kronos Bio, Inc. | 54.2 Million USD | -415.834% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -494.322% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1128.428% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1292.99% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1132.94% |
| ImmunityBio, Inc. | 1.09 Billion USD | 74.359% |
| Korro Bio, Inc. | 51.75 Million USD | -440.244% |
| Kineta, Inc. | 7.22 Million USD | -3771.324% |
| BioVie Inc. | 9.7 Million USD | -2781.707% |
| Codexis, Inc. | 49.94 Million USD | -459.779% |
| Celularity Inc. | 102.92 Million USD | -171.631% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -190.489% |
| Celcuity Inc. | 51.45 Million USD | -443.414% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -80894.166% |
| Cibus, Inc. | 206.11 Million USD | -35.645% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -558.239% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -961.494% |
| IN8bio, Inc. | 8.77 Million USD | -3087.266% |
| Kodiak Sciences Inc. | 213.59 Million USD | -30.898% |
| Annexon, Inc. | 47.11 Million USD | -493.376% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -212.245% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -190.112% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1942.421% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.261% |
| Eyenovia, Inc. | 19.78 Million USD | -1313.463% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -57.882% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3539.982% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1060.16% |
| Arcellx, Inc. | 339.75 Million USD | 17.709% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2249.866% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -13.866% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2823.633% |
| Moolec Science SA | 13.94 Million USD | -1904.875% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -547.912% |
| Geron Corporation | 146.12 Million USD | -91.332% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -453.287% |
| Royalty Pharma plc | 6.29 Billion USD | 95.56% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -602.904% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -94866.475% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -11264.022% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -47.808% |
| Humacyte, Inc. | 114.67 Million USD | -143.804% |
| Structure Therapeutics Inc. | 29.05 Million USD | -862.4% |
| 89bio, Inc. | 59.96 Million USD | -366.266% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -956.52% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -23276.839% |
| Genelux Corporation | 8.42 Million USD | -3220.511% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3977.99% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -105.098% |
| Notable Labs, Ltd. | 4.42 Million USD | -6215.496% |
| Liquidia Corporation | 73.13 Million USD | -282.273% |
| Mustang Bio, Inc. | 17.61 Million USD | -1486.849% |
| Immunovant, Inc. | 48.95 Million USD | -471.11% |
| Quantum-Si incorporated | 26.63 Million USD | -949.855% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -628.414% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8910.216% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -278.531% |
| Acasti Pharma Inc. | 11.55 Million USD | -2319.2% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1136.688% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10184.961% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -658.161% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -20414.997% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4486.401% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1025.778% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1105.948% |
| PepGen Inc. | 34.63 Million USD | -707.332% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2202.264% |
| United Therapeutics Corporation | 1.18 Billion USD | 76.35% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3903.25% |
| Solid Biosciences Inc. | 38.45 Million USD | -626.993% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3167.275% |
| Immuneering Corporation | 12 Million USD | -2228.271% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -88980.731% |
| Silo Pharma, Inc. | 1.56 Million USD | -17716.373% |
| Belite Bio, Inc | 4.21 Million USD | -6539.444% |
| XOMA Corporation | 145.58 Million USD | -92.05% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -11415.115% |
| Bionomics Limited | 10.15 Million USD | -2652.187% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1200.949% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1120.211% |
| uniQure N.V. | 624.01 Million USD | 55.196% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1869.616% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -154623.549% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -64.285% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7526.487% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -107192.878% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -4043.871% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3539.982% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1508.393% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2545.6% |
| Altimmune, Inc. | 16.54 Million USD | -1590.267% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 54.738% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1120.211% |
| Compugen Ltd. | 55.77 Million USD | -401.277% |
| Peak Bio, Inc. | 20.75 Million USD | -1247.189% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -153.105% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5534.563% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -77.13% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -271.92% |
| Zura Bio Limited | 21.29 Million USD | -1213.108% |
| PolyPid Ltd. | 17.46 Million USD | -1500.567% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -148.745% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -271.92% |
| Instil Bio, Inc. | 99.8 Million USD | -180.144% |
| argenx SE | 444.95 Million USD | 37.165% |
| Immunome, Inc. | 28.65 Million USD | -875.598% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3253.568% |
| Verona Pharma plc | 58.84 Million USD | -375.157% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1831.783% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1781.6% |
| CervoMed Inc. | 2.59 Million USD | -10670.965% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5636.295% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2095.25% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2553.887% |
| Moolec Science SA | 13.94 Million USD | -1904.875% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11830.298% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -402.897% |
| AnaptysBio, Inc. | 364.28 Million USD | 23.251% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2238.466% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2104.249% |
| NeurAxis, Inc. | 1.91 Million USD | -14517.101% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -618.216% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1996.955% |
| Achilles Therapeutics plc | 19.08 Million USD | -1364.803% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1831.783% |
| 180 Life Sciences Corp. | 5.38 Million USD | -5089.83% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1085.294% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1128.428% |
| Nutriband Inc. | 1.07 Million USD | -25813.623% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -813.743% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1826.725% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 30.325% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -760.983% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2042.578% |
| Palisade Bio, Inc. | 2.73 Million USD | -10107.631% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -5222.425% |
| Beam Therapeutics Inc. | 478.38 Million USD | 41.556% |
| Neurogene Inc. | 36.54 Million USD | -664.965% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 29.743% |
| AEON Biopharma, Inc. | 159.88 Million USD | -74.863% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -486.751% |
| Sesen Bio, Inc. | 30.98 Million USD | -802.359% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -976.95% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3577.704% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -42.837% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -45.575% |
| Athira Pharma, Inc. | 30.05 Million USD | -830.189% |
| Vaccinex, Inc. | 5.94 Million USD | -4605.268% |
| HCW Biologics Inc. | 15.05 Million USD | -1757.481% |
| XOMA Corporation | 145.58 Million USD | -92.05% |
| Nektar Therapeutics | 267.04 Million USD | -4.696% |
| Arvinas, Inc. | 644.6 Million USD | 56.626% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1476.636% |
| Merus N.V. | 102.15 Million USD | -173.7% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -91.04% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -193.931% |
| Rezolute, Inc. | 11.73 Million USD | -2282.708% |
| Clene Inc. | 38.95 Million USD | -617.792% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9719.097% |
| BeyondSpring Inc. | 48.26 Million USD | -479.227% |
| Synlogic, Inc. | 32.89 Million USD | -749.938% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1813.276% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -17010.588% |
| Peak Bio, Inc. | 20.75 Million USD | -1247.189% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -340.579% |
| Krystal Biotech, Inc. | 39.71 Million USD | -604.001% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 25.769% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -180.797% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -64510.631% |
| MannKind Corporation | 721.36 Million USD | 61.242% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1151.789% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -13303.02% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -172.529% |
| Gossamer Bio, Inc. | 249.14 Million USD | -12.218% |
| CohBar, Inc. | 1.03 Million USD | -26948.831% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2515.652% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1367.802% |
| Legend Biotech Corporation | 589.93 Million USD | 52.607% |
| Mural Oncology plc | 37.92 Million USD | -637.152% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -110.793% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -12080.678% |
| Disc Medicine, Inc. | 22.87 Million USD | -1122.238% |
| Champions Oncology, Inc. | 28.03 Million USD | -897.278% |
| REGENXBIO Inc. | 262.22 Million USD | -6.62% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -8222.647% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2130.629% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1981.557% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1218.496% |
| Vaxart, Inc. | 34.02 Million USD | -721.711% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1271.246% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -879.911% |
| Cellectis S.A. | 249.57 Million USD | -12.025% |
| Longeveron Inc. | 5.33 Million USD | -5138.655% |
| Repare Therapeutics Inc. | 41.81 Million USD | -568.565% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.376% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -363.138% |
| Revolution Medicines, Inc. | 262.39 Million USD | -6.551% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -13169.435% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3141.213% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2269.181% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1890.935% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -12898.001% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.571% |
| Denali Therapeutics Inc. | 122.96 Million USD | -127.375% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4924.121% |
| Veru Inc. | 32.81 Million USD | -752.069% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3970.272% |
| Cingulate Inc. | 10.36 Million USD | -2598.491% |
| Passage Bio, Inc. | 39.26 Million USD | -612.106% |
| Context Therapeutics Inc. | 4.19 Million USD | -6569.991% |
| Exicure, Inc. | 8.54 Million USD | -3170.406% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -847.496% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2566.288% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1168.486% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -71.541% |
| Nuvalent, Inc. | 31.82 Million USD | -778.569% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4294.898% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -343.634% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1453.261% |
| OmniAb, Inc. | 87.4 Million USD | -219.894% |
| Anew Medical, Inc. | 8.24 Million USD | -3292.305% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -630.2% |
| Lipocine Inc. | 2.63 Million USD | -10524.104% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -964.201% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -595.283% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -949.429% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -224.52% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -5076.578% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -237.882% |
| Ocugen, Inc. | 23.98 Million USD | -1065.772% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -502.467% |
| Q32 Bio Inc. | 233.12 Million USD | -19.929% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2983.907% |
| Alumis Inc. Common Stock | 53.5 Million USD | -422.573% |
| Equillium, Inc. | 27.95 Million USD | -900.061% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -35.333% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4868.965% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4458.755% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -77.712% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -302.672% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2703.102% |
| Dominari Holdings Inc. | 4.63 Million USD | -5932.082% |
| Edesa Biotech, Inc. | 1.84 Million USD | -15081.439% |
| vTv Therapeutics Inc. | 29.56 Million USD | -845.605% |
| Bio-Techne Corporation | 744.34 Million USD | 62.438% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -121.72% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 18.832% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -589.062% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -865.525% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -202.714% |
| Nkarta, Inc. | 105.6 Million USD | -164.76% |
| BioCardia, Inc. | 4.59 Million USD | -5991.22% |
| Iterum Therapeutics plc | 32.66 Million USD | -756.001% |